These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 867499)

  • 1. Efficacy of matched platelet transfusions from unrelated donors.
    Radvany R; Green D; Rossi EC; Draugelis AK; Kahan BD
    Transplant Proc; 1977 Mar; 9(1):513-7. PubMed ID: 867499
    [No Abstract]   [Full Text] [Related]  

  • 2. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L; Woodfield DG
    N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion strategy: use of HLA-matched platelet transfusions for alloimmunized patients.
    Menitove JE; Duquesnoy RJ
    Am J Med Technol; 1981 Feb; 47(2):114-20. PubMed ID: 7223758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet crossmatch testing for donor selection.
    Slichter SJ
    Prog Clin Biol Res; 1982; 88():153-64. PubMed ID: 7100207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of patients with hematologic malignancies and aplastic anemia who are refractory to platelet transfusions.
    Sandler SG
    Haematologia (Budap); 1998; 29(1):1-11. PubMed ID: 9704252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supportive haemotherapy in bone marrow transplantation.
    Mayr WR
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):455-8. PubMed ID: 2480289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experience of HLA-matched platelet transfusion in patients who are refractory to random donor platelets].
    Sekiguchi S; Mitani T; Ohnuma M; Katoh T; Ikeda H; Nakase T; Morioka M; Sakurada K; Miyazaki T
    Hokkaido Igaku Zasshi; 1988 Jul; 63(4):552-61. PubMed ID: 3220437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Severe aplastic anemia treated with HLA-matched platelet transfusion].
    Nozaki H; Yonekura S; Komatsuda M; Watanabe K; Nagao T; Arimori S
    Rinsho Ketsueki; 1986 Aug; 27(8):1410-4. PubMed ID: 3795515
    [No Abstract]   [Full Text] [Related]  

  • 9. [The need of a registry of HLA-phenotyped platelet donors].
    Castro Izaguirre E; Muncunill Ribas J
    Med Clin (Barc); 1995 Nov; 105(18):696-9. PubMed ID: 8538251
    [No Abstract]   [Full Text] [Related]  

  • 10. [Practical usefulness of a donor registry with determined HLA class I antigens--current personal experience].
    Gronkowska A; Uhrynowska M; Gromadzka G; Zupańska B
    Acta Haematol Pol; 1993; 24(2):161-7. PubMed ID: 8372616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Status of data of HLA-typed donors for unrelated bone marrow transplantation in Hannover: organization and results].
    Müller R; Riedel T; Stangel W
    Beitr Infusionsther; 1990; 26():211-3. PubMed ID: 1703833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological aspects of platelet transfusions.
    Murphy MF; Waters AH
    Br J Haematol; 1985 Jul; 60(3):409-14. PubMed ID: 4015986
    [No Abstract]   [Full Text] [Related]  

  • 13. [Selection of HLA compatible donors for patients with HLA antibodies].
    Májský A; Korínková P; Kubícková Z
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(6):937-43. PubMed ID: 2419224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of compatible platelet donors: a prospective evaluation of three cross-matching techniques.
    Wu KK; Hoak JC; Koepke JA; Thompson JS
    Transfusion; 1977; 17(6):638-43. PubMed ID: 145673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The HLA crossmatching test before thrombocyte transfusion. Comparison of 3 methods].
    Májský A; Prazák J
    Vnitr Lek; 1990 Sep; 36(9):873-8. PubMed ID: 2251774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Approaches to the immunological problems of leukocyte transfusions].
    Gualde N; Malinvaud G; Gaillard S
    Nouv Rev Fr Hematol; 1975; 15(3):376-9. PubMed ID: 128738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of an appropriate size of unrelated donor pool to be registered for HLA-matched platelet transfusion.
    Takahashi K; Juji T; Miyazaki H
    Transfusion; 1987; 27(5):394-8. PubMed ID: 3477043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transfusion of platelet concentrates].
    Rieux C; Lee K; Lavaud A; Bierling P
    Ann Med Interne (Paris); 1999 Dec; 150(8):631-41. PubMed ID: 10686645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Platelet cross-matching].
    Shibata Y; Juji T
    Rinsho Ketsueki; 1978 Oct; 19(10):1429-31. PubMed ID: 739603
    [No Abstract]   [Full Text] [Related]  

  • 20. [Optimal donor selection and the effectiveness of platelet transfusion in cases refractory to platelet transfusion].
    Iwanaga T; Tsubaki K; Horiuchi A; Fujikawa Y; Kanemitsu Y
    Rinsho Ketsueki; 1986 Jul; 27(7):1274-7. PubMed ID: 3784009
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.